Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts
Recruiting
N/A
Interventional Study
Periodontitis
Intrabony Periodontal Defect
Periodontal Diseases
Periodontal Defect
Periodontal Bone Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 16 (estimated)
- Sponsor
- Saglik Bilimleri Universitesi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The use of injectable platelet-rich fibrin (i-PRF) in both surgical and non-surgical dental treatments has become increasingly widespread. Hard tissue grafts can produce "sticky bone," and bone gain can have a positive effect on intrabony defects frequently seen in periodontal disease, compared to grafts alone. This study aims to clinically and radiographically evaluate the effectiveness of using …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male and female patients aged 18-65 years
* Patients with Stage III Periodontitis according to the AAP-EFP 2017 Periodontal Disease Classification
* PPD≥5 mm (if persistent 6 weeks after initial periodontal treatment)
* Intrabony defects in the interproximal region with 2 or 3…
Contacts